Opportunity
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed) PAR-19-347
Award Info:
New Investigators, who have not received independent NIH funding, and investigators who are new to PID research are especially encouraged to apply to this FOA.
A budget for direct costs of up to $50,000 per year may be requested (i.e. a maximum of $100,000 over two years)
Description:
The purpose of this Funding Opportunity Announcement (FOA) is to support the discovery and characterization of primary immunodeficiency diseases, also referred to as inborn errors of immunity, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders.